International Journal of Ophthalmology, Journal Year: 2024, Volume and Issue: 17(11), P. 1995 - 2006
Published: Oct. 23, 2024
AIM: To investigate the proliferation regulatory effect of cone-rod homeobox (CRX) in retinal pigment epithelium (RPE) and retinoblastoma (RB) cells to explore potential application side (oncogenic potential) CRX-based gene therapy RPE-based retinopathies. METHODS: Adult human epithelial (ARPE)-19 (RPE)-1 Y79 RB cell were used study. Genetic manipulation was performed by lentivirus-based technology. The determined a CellTiter-Glo Reagent. mRNA protein levels quantitative real-time polymerase chain reaction (qPCR) Western blot assay. transcriptional activity promoter luciferase reporter bindings between CRX transcription factor 7 (TCF7) as well TCF7 promoters target genes examined chromatin immunoprecipitation (ChIP) modified nuclear run-on RESULTS: overexpression knockdown significantly increased (n=3, P<0.05 all cells) decreased P<0.01 RPE cells. deceased Wnt signaling [including MYC proto-oncogene (MYC), JUN, FOS like 1 (FOSL1), CCND1, cyclin D2 (CCND2), D3 (CCND3), cellular communication network 4 (CCN4), peroxisome proliferator activated receptor delta (PPARD), matrix metallopeptidase (MMP7)] driven (TCF7). depletion abolished stimulatory on level immunoprecipitated antibody. CONCLUSION: transcriptionally activates promote vitro. is for regenerative medicine. risk this strategy, tumorigenic potential, should be considered.
Language: Английский